InvestorsHub Logo
Followers 87
Posts 6643
Boards Moderated 1
Alias Born 09/18/2009

Re: None

Monday, 07/31/2023 6:51:53 PM

Monday, July 31, 2023 6:51:53 PM

Post# of 42755
So, an ETF with a phytomedical research and biopharmaceutical drug development company?

Targeting Cytokine release syndrome, or CRS...potential to reset the body’s immune system after triggering hyperinflammation. Post-exposure target population...